203 related articles for article (PubMed ID: 22410646)
1. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.
Ambrose CS; Dubovsky F; Yi T; Belshe RB; Ashkenazi S
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2549-57. PubMed ID: 22410646
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
3. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.
Gaglani MJ; Piedra PA; Riggs M; Herschler G; Fewlass C; Glezen WP
Pediatr Infect Dis J; 2008 May; 27(5):444-52. PubMed ID: 18401289
[TBL] [Abstract][Full Text] [Related]
4. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season.
Tennis P; Toback SL; Andrews EB; McQuay LJ; Ambrose CS
Vaccine; 2012 Sep; 30(42):6099-102. PubMed ID: 22841479
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated influenza vaccine use and safety in children and adults with asthma.
Duffy J; Lewis M; Harrington T; Baxter R; Belongia EA; Jackson LA; Jacobsen SJ; Lee GM; Naleway AL; Nordin J; Daley MF;
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):439-444. PubMed ID: 28390584
[TBL] [Abstract][Full Text] [Related]
6. An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years.
Ambrose CS; Yi T; Falloon J
Influenza Other Respir Viruses; 2011 Nov; 5(6):389-97. PubMed ID: 21668683
[TBL] [Abstract][Full Text] [Related]
7. A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
Toback SL; Ambrose CS; Eaton A; Hansen J; Aukes L; Lewis N; Wu X; Baxter R
Vaccine; 2013 Apr; 31(14):1812-8. PubMed ID: 23395734
[TBL] [Abstract][Full Text] [Related]
8. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.
Tennis P; Toback SL; Andrews E; McQuay LJ; Ambrose CS
Vaccine; 2011 Jul; 29(31):4947-52. PubMed ID: 21596087
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.
Carter NJ; Curran MP
Drugs; 2011 Aug; 71(12):1591-622. PubMed ID: 21861544
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink.
Caspard H; Steffey A; Mallory RM; Ambrose CS
BMJ Open; 2018 Dec; 8(12):e023118. PubMed ID: 30530581
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
[TBL] [Abstract][Full Text] [Related]
12. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.
Hoft DF; Babusis E; Worku S; Spencer CT; Lottenbach K; Truscott SM; Abate G; Sakala IG; Edwards KM; Creech CB; Gerber MA; Bernstein DI; Newman F; Graham I; Anderson EL; Belshe RB
J Infect Dis; 2011 Sep; 204(6):845-53. PubMed ID: 21846636
[TBL] [Abstract][Full Text] [Related]
13. Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age.
Miller EK; Dumitrescu L; Cupp C; Dorris S; Taylor S; Sparks R; Fawkes D; Frontiero V; Rezendes AM; Marchant C; Edwards KM; Crawford DC
Vaccine; 2011 Apr; 29(18):3431-7. PubMed ID: 21396408
[TBL] [Abstract][Full Text] [Related]
14. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
[TBL] [Abstract][Full Text] [Related]
15. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
[TBL] [Abstract][Full Text] [Related]
16. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
[TBL] [Abstract][Full Text] [Related]
17. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.
Ambrose CS; Levin MJ; Belshe RB
Influenza Other Respir Viruses; 2011 Mar; 5(2):67-75. PubMed ID: 21306569
[TBL] [Abstract][Full Text] [Related]
18. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.
Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS
Vaccine; 2012 Apr; 30(19):2989-98. PubMed ID: 22386746
[TBL] [Abstract][Full Text] [Related]
19. Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma.
Turner PJ; Fleming L; Saglani S; Southern J; Andrews NJ; Miller E;
J Allergy Clin Immunol; 2020 Apr; 145(4):1157-1164.e6. PubMed ID: 31863808
[TBL] [Abstract][Full Text] [Related]
20. Emerging data on the safety and efficacy of influenza vaccines in children.
Vesikari T
Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
